Navigation Links
BioVex to Report Phase II Clinical Trial Results of OncoVEX GM-CSF in Metastatic Melanoma at the 2008 American Society of Clinical Oncology Meeting
Date:5/16/2008

vast majority of experimental therapies have failed to show more than a single digit response rate.

About BioVex

BioVex is a privately held biotechnology Company based in Woburn. MA. The Company is developing a new class of potent biologics for the treatment of cancer and prevention of infectious disease.

The Company's lead cancer technology platform, OncoVEX GM-CSF, is an unpartnered, first-in-class oncolytic, or cancer destroying virus technology. OncoVEX GM-CSF works by: 1) replicating and spreading within solid tumors, causing the death of cancer cells; while 2) stimulating the immune system to destroy metastatic deposits. Both modes of action have been clearly validated in the clinic, where multiple patients with metastatic disease progressing at enrollment have been declared disease free. BioVex believes OncoVEX GM-CSF has the potential to become a leading standard of care in the treatment of many solid tumors based on the strength of clinical data generated to date, coupled with a benign side effect profile.

BioVex is currently completing a Phase II clinical trial of OncoVEX GM-CSF for melanoma and Phase I/II clinical trials for head & neck cancer and pancreatic cancer. The Company recently announced that the FDA has approved the design of a single, pivotal Phase III clinical trial evaluating OncoVEX GM-CSF in previously treated patients with metastatic melanoma under the Special Protocol Assessment (SPA) procedure and plans to make a second SPA submission for head & neck cancer later in the year.

The Company's second program is a vaccine for genital herpes, ImmunoVEX HSV2, which provides complete protection in animal models of the disease. A Phase I study with ImmunoVEX HSV2 is scheduled to commence in the third quarter of 2008.

For further information, please go to http://www.biovex.com.


'/>"/>
SOURCE BioVex Inc
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. BioVex Agrees SPA With the FDA for a Pivotal Study With OncoVEX(GM-CSF) in Metastatic Melanoma and Announces Presentation of Phase II Results at ASCO
2. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
3. Spherix Reports Second Quarter Earnings
4. You May Have a Thyroid Problem and Not Know It - Particularly If Youre Over 60, Says a New Harvard Medical School Report
5. Tapestry Reports Second Quarter 2007 Results
6. Callisto Reports on Second-Quarter 2007 Milestones
7. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
8. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
9. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
10. TAXUS WOMAN Study Reports Positive Clinical Outcomes for the TAXUS(R) Drug-eluting Stent in Women
11. Biopure Reports on Meeting with the FDA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... York , July 22, 2014 ... Transparency Market Research "Process Spectroscopy Market (Technology Types - Near ... spectroscopy) Market - Global Industry Analysis, Size, Share, Growth, Trends ... USD 714.5 million in 2012 and is expected to grow ... North America was the largest ...
(Date:7/22/2014)... July 22, 2014 BiologicTx ® today ... first 3-way Kidney Paired Donation transplant exchange utilizing BiologicTx,s ... on July 9 at the Miami Transplant Institute, located ... Kidney Paired Donation (KPD) ... compatible for kidney transplant with one another due to ...
(Date:7/22/2014)... , July 22, 2014 Sanofi Pasteur, the ... SNY ), announced today that the first lots of Fluzone ... season have been released by the U.S. Food and Drug ... 21, 2014, representing the first of at least 65 million ... will be delivered to U.S. health care providers and pharmacies ...
Breaking Medicine Technology:Process Spectroscopy Market Expected to Reach USD 1,179.6 Million in 2019: Transparency Market Research 2Process Spectroscopy Market Expected to Reach USD 1,179.6 Million in 2019: Transparency Market Research 3Process Spectroscopy Market Expected to Reach USD 1,179.6 Million in 2019: Transparency Market Research 4BiologicTx Paired Donation Aids In Successful Kidney Transplants 2BiologicTx Paired Donation Aids In Successful Kidney Transplants 3Sanofi Pasteur Begins Shipping Seasonal Influenza Vaccine for Upcoming 2014-2015 Season in United States 2Sanofi Pasteur Begins Shipping Seasonal Influenza Vaccine for Upcoming 2014-2015 Season in United States 3Sanofi Pasteur Begins Shipping Seasonal Influenza Vaccine for Upcoming 2014-2015 Season in United States 4Sanofi Pasteur Begins Shipping Seasonal Influenza Vaccine for Upcoming 2014-2015 Season in United States 5Sanofi Pasteur Begins Shipping Seasonal Influenza Vaccine for Upcoming 2014-2015 Season in United States 6Sanofi Pasteur Begins Shipping Seasonal Influenza Vaccine for Upcoming 2014-2015 Season in United States 7
... Bacterin International Holdings, Inc. ("Bacterin") (NYSE Amex: ... revolutionary bone graft material and antimicrobial coatings for medical ... the Company,s third human acellular biological scaffold, hMatrix®, an ... an acellular matrix processed from donated human dermal tissue ...
... 5, 2011 AmbiCom Holdings, Inc. (OTCQB:ABHI), ... medical equipment suppliers, today announced that it has retained ... firm, to develop and implement a strategic investor relations ... with the investment community. "Wireless medical ...
Cached Medicine Technology:Bacterin International Holdings Launches Third Biologic Scaffold 2Bacterin International Holdings Launches Third Biologic Scaffold 3AmbiCom Retains Hayden IR to Develop Strategic Investor Relations Program 2AmbiCom Retains Hayden IR to Develop Strategic Investor Relations Program 3
(Date:7/22/2014)... Marine threats from human or natural agents ... and international criminal and piracy threats have created ... systems. Due to this the worldwide revenue of ... 2014 and is expected to reach $20.87 billion ... expected to grow at a CAGR of 8.40%. ...
(Date:7/22/2014)... HealthDay Reporter TUESDAY, July 22, 2014 (HealthDay ... survival and the course of the disease in people with ... researchers report. , , The components in the blood that ... called albumin and creatinine. These components are normally tested to ... Library of Medicine. But now it appears that these ...
(Date:7/22/2014)... Virginia Commonwealth University has received a five-year, $3 ... as severe illnesses, neglect and maltreatment during childhood ... risks later in life. , The Center for ... School of Pharmacy, in collaboration with Duke University ... which is funded by the National Institutes of ...
(Date:7/22/2014)... Scientists attached radio-frequency identification (RFID) tags to hundreds of ... effort yielded two discoveries: Some foraging bees are much busier ... take their place. , The findings are reported ... bees revealed that about 20 percent of the foraging bees ... nectar and pollen gathered to feed the hive. , "We ...
(Date:7/22/2014)... Today, Therapy Changes announces the start of their Teen ... help increase their knowledge and ability to cope with life’s ... to make healthy and positive decisions while connecting with like-minded ... but also a time of major life transition and stress,” ... . , “Teens can at times feel misunderstood, so rather ...
Breaking Medicine News(10 mins):Health News:North America Maritime Security Market is Expected to Reach $4.76 billion in 2019 - New Report by MicroMarket Monitor 2Health News:North America Maritime Security Market is Expected to Reach $4.76 billion in 2019 - New Report by MicroMarket Monitor 3Health News:North America Maritime Security Market is Expected to Reach $4.76 billion in 2019 - New Report by MicroMarket Monitor 4Health News:Blood Test Might Help Predict Survival With Lou Gehrig's Disease 2Health News:Blood Test Might Help Predict Survival With Lou Gehrig's Disease 3Health News:VCU receives grant to study molecular marks left by childhood adverse experiences 2Health News:Radio frequency ID tags on honey bees reveal hive dynamics 2Health News:Therapy Changes Announces Teen Support Group Therapy 2
... M. Jackson Foundation for the Advancement of Military Medicine, ... anesthesiology residents in the art and science of advanced ... aim is to serve as a resource to manage ... Military Advanced Regional Anesthesia and Analgesia Handbook " is ...
... Net and Elderly Care in Underserved Communities , ... announced today that it has approved more than 400 ... first quarter of 2009. The not-for-profit health care organization,s ... care in the safety net and improving care for ...
... promoting a painless new method for detecting diabetes, ... at the American Association of Clinical Endocrinologists (AACE) ... Texas.(Logo: http://www.newscom.com/cgi-bin/prnh/20090324/DC88061LOGO-b ... diabetes, doctors examined the saliva of 40 different ...
... Non Dues Revenue for the Texas Medical ... launched MedBuzz, a powerful new online advertising ... Medical Association that has extended TMA,s online ... generated incremental non-dues revenue for the largest ...
... April 28 MinuteClinic, the pioneer and largest ... States, announced that it has become a participating ... insurer in Pennsylvania based on membership.Members of Highmark,s ... care centers located inside select CVS/pharmacy stores in ...
... SARS, and true severity of outbreak still unknown , , TUESDAY, April ... flu in Mexico rises and new cases appear in the United ... sense of mounting dread. , But experts in influenza and infectious ... still far from certain. , "This is something of concern [but] ...
Cached Medicine News:Health News:HJF publishes handbook on managing pain of battlefield trauma 2Health News:Kaiser Permanente Approves $13 Million in Community Benefit Grants in First Quarter of 2009 2Health News:Kaiser Permanente Approves $13 Million in Community Benefit Grants in First Quarter of 2009 3Health News:Kaiser Permanente Approves $13 Million in Community Benefit Grants in First Quarter of 2009 4Health News:Detecting Diabetes Without a Needle: The Spit Factor 2Health News:Audience Generation, LLC Launches MedBuzz for Texas Medical Association 2Health News:Audience Generation, LLC Launches MedBuzz for Texas Medical Association 3Health News:MinuteClinic Becomes Participating Provider With Highmark Inc. 2Health News:MinuteClinic Becomes Participating Provider With Highmark Inc. 3Health News:Experts Say Panic Over Swine Flu Is Premature 2Health News:Experts Say Panic Over Swine Flu Is Premature 3Health News:Experts Say Panic Over Swine Flu Is Premature 4Health News:Experts Say Panic Over Swine Flu Is Premature 5
Non-Illuminated Trial Lens Set with lenses mounted in plastic frames....
Illuminated Trial Lens Set is an attractive set of trial lenses worked to a high standard of accuracy....
Minus cylinders only trial lens set....
Full Trial Lens Set....
Medicine Products: